NDC 10702-001

LOMAIRA

Phentermine Hydrochloride

LOMAIRA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Kvk-tech, Inc.. The primary component is Phentermine Hydrochloride.

Product ID10702-001_7d63504d-5cb7-504f-e053-2991aa0aec29
NDC10702-001
Product TypeHuman Prescription Drug
Proprietary NameLOMAIRA
Generic NamePhentermine Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-09-12
Marketing CategoryANDA / ANDA
Application NumberANDA203495
Labeler NameKVK-TECH, INC.
Substance NamePHENTERMINE HYDROCHLORIDE
Active Ingredient Strength8 mg/1
Pharm ClassesAppetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 10702-001-03

30 TABLET in 1 BOTTLE (10702-001-03)
Marketing Start Date2016-09-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10702-001-06 [10702000106]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-12

NDC 10702-001-03 [10702000103]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-12

NDC 10702-001-10 [10702000110]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-12

NDC 10702-001-09 [10702000109]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-12

NDC 10702-001-25 [10702000125]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-12

NDC 10702-001-50 [10702000150]

LOMAIRA TABLET
Marketing CategoryANDA
Application NumberANDA203495
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-12

Drug Details

Active Ingredients

IngredientStrength
PHENTERMINE HYDROCHLORIDE8 mg/1

OpenFDA Data

SPL SET ID:cde9fb09-e5af-434d-8874-e4f9f974d893
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1810304
  • 826919
    • UPC Code
  • 0310702001091

    • Pharmacological Class

    • Appetite Suppression [PE]
    • Increased Sympathetic Activity [PE]
    • Sympathomimetic Amine Anorectic [EPC]
    • Appetite Suppression [PE]
    • Increased Sympathetic Activity [PE]
    • Sympathomimetic Amine Anorectic [EPC]

    Medicade Reported Pricing

    10702001850 OXYCODONE HCL 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001801 OXYCODONE HCL 5 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001724 CHLORPHENIRAMINE ER 12 MG TAB

    Pricing Unit: EA | Drug Type:

    10702001706 CHLORPHENIRAMINE ER 12 MG TAB

    Pricing Unit: EA | Drug Type:

    10702001650 INDOMETHACIN ER 75 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    10702001610 INDOMETHACIN ER 75 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    10702001606 INDOMETHACIN ER 75 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    10702001603 INDOMETHACIN ER 75 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    10702001601 INDOMETHACIN ER 75 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    10702001301 BETAXOLOL 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001250 HYDROXYZINE HCL 50 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001210 HYDROXYZINE HCL 50 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001201 HYDROXYZINE HCL 50 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001150 HYDROXYZINE HCL 25 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001110 HYDROXYZINE HCL 25 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001101 HYDROXYZINE HCL 25 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001050 HYDROXYZINE HCL 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001010 HYDROXYZINE HCL 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    10702001001 HYDROXYZINE HCL 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "LOMAIRA" or generic name "Phentermine Hydrochloride"

    NDCBrand NameGeneric Name
    10702-001LOMAIRAPhentermine Hydrochloride
    63629-7874LOMAIRALOMAIRA
    0185-0644phentermine hydrochloridephentermine hydrochloride
    0185-0647phentermine hydrochloridephentermine hydrochloride
    0185-5000phentermine hydrochloridephentermine hydrochloride
    0527-0597Phentermine HydrochloridePhentermine Hydrochloride
    0527-1308Phentermine HydrochloridePhentermine Hydrochloride
    0527-1310Phentermine HydrochloridePhentermine Hydrochloride
    0527-1438Phentermine HydrochloridePhentermine Hydrochloride
    0527-1445Phentermine HydrochloridePhentermine Hydrochloride
    0527-1742Phentermine HydrochloridePhentermine Hydrochloride
    0527-1743Phentermine HydrochloridePhentermine Hydrochloride
    10544-098Phentermine HydrochloridePhentermine Hydrochloride
    10544-099Phentermine HydrochloridePhentermine Hydrochloride
    10544-116Phentermine HydrochloridePhentermine Hydrochloride
    10544-552Phentermine HydrochloridePhentermine Hydrochloride
    10544-592Phentermine HydrochloridePhentermine Hydrochloride
    10544-593Phentermine HydrochloridePhentermine Hydrochloride
    10544-602Phentermine HydrochloridePhentermine Hydrochloride
    10544-620Phentermine HydrochloridePhentermine Hydrochloride
    10702-025Phentermine HydrochloridePhentermine Hydrochloride
    10702-026Phentermine HydrochloridePhentermine Hydrochloride
    10702-027Phentermine HydrochloridePhentermine Hydrochloride
    10702-028Phentermine HydrochloridePhentermine Hydrochloride
    10702-029Phentermine HydrochloridePhentermine Hydrochloride
    10702-067Phentermine HydrochloridePhentermine Hydrochloride
    11534-157Phentermine Hydrochloridephentermine hydrochloride
    11534-159Phentermine hydrochloridephentermine hydrochloride

    Trademark Results [LOMAIRA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LOMAIRA
    LOMAIRA
    86579836 5191785 Live/Registered
    AVANTHI, Inc.
    2015-03-28
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.